Catalyst Wire Dossier Catalyst Wire Dossier

Siponimod

siponimod · Novartis
Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for Siponimod, covering 2024-09-19 to 2026-04-29. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Safety of Ofatumumab and Siponimod Compared to Fingolimod in Pediatric Patients With Multiple Sclerosis [Phase 3]

See pricing